Psilocybin NewsPsilocybin News — Psilocybin research, therapy and policy. READ THE NEWS

Terms and Conditions

Last updated: October 29, 2026

By using Psilocybin News, operated by Ketamine Media, you agree to these Terms and Conditions.

Information only — not medical advice

Articles on this site are for general news and educational purposes about psilocybin and psychedelic-assisted therapy. They are not medical advice, and they are not an endorsement of obtaining or using psilocybin outside of licensed treatment or research. Psilocybin remains a controlled substance in most places and can be unsafe for some people. Always speak to a qualified healthcare professional before making decisions about any treatment.

Our content

All articles, images and branding on this site belong to Ketamine Media or their respective owners. You may share links to our articles, but you may not republish our content without permission.

Accuracy

We work to keep our reporting accurate and up to date, but we cannot guarantee that every article is complete or current.

Third-party links and adverts

We may link to other websites and display adverts. We do not control and are not responsible for third-party content, products or services.

Acceptable use

Please do not misuse the site, attempt to disrupt it, or use it for anything unlawful.

Changes

We may update these terms from time to time. Continued use of the site means you accept the latest version.

Contact

Ketamine Media, 611 King St NW Suite 200B, Knoxville, TN 37917
contact@ketaminemedia.com

Subscribe to news updates